ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 633207 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 633207; 2) Community: the network communities that were significantly associated with the response to NSC 633207; 3) Molecule: the relationships between components within communities and NSC 633207; 4) MDR: the compounds that were significantly associated with the NSC 633207.

NSC Compound Enrichment Correlation
NSC 291926 Null 3.52090010908445e-005 0.46658269
NSC 174121 Methotrexate Derivative 5.8810601870556e-006 0.2191288
NSC 626433 3-Nitro-5-formylisoxazole 5.8810601870556e-006 0.40480485
NSC 139105 Soluble Baker's Antifol 6.67967536140749e-005 0.25794875
NSC 305782 2,4-Quinazolinediamine, 6-[[3-(trifluoromethyl)phenyl]thio]- 6.67967536140749e-005 0.24630873
NSC 618261 2H-1-Benzopyran, 6-methoxy-3-nitro-2-[2,2,2',2'-tetramethyl (4,4'-bi-1,3-dioxolan)-5-yl]- 6.67967536140749e-005 0.59775056
NSC 701314 1H,3H-Thiazolo[3,4-a]benzimidazole, 1-(2,6-dichlorophenyl)-6-methoxy- 6.67967536140751e-005 0.26068573
NSC 707982 Null 6.67967536140751e-005 0.39881726
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 6.67967536140751e-005 0.26014636
NSC 663286 7-Chloro-6-N-(2-fluoroethylamino)-5,8-quinolinedione 6.74487631170136e-005 0.50309596
Total:102  Current:101    [First] [Prev] [Next] [Last]